AUTH/2105/3/08: Anonymous doctor v Procter & Gamble (Asacol) — patient recruitment poster (no breach)

📅 2008 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2105/3/08
ComplainantAnonymous doctor (non-contactable)
CompanyProcter & Gamble Pharmaceuticals UK Limited
ProductAsacol (mesalazine)
IssueAlleged promotion of Asacol to the public via a hospital poster recruiting for the CODA trial (“Once daily Asacol”)
Company involvementEducational grant funding only; no role in poster creation or placement (poster produced by NHS trust sponsor; REC approved)
Applicable Code year2006
Clauses considered2, 9.1, 20.1, 20.2
DecisionNo breach of Clauses 2, 9.1, 20.1 and 20.2
Complaint received13 March 2008
Case completed9 April 2008
AppealNo appeal

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • An anonymous doctor complained about a poster in a hospital outpatients department recruiting patients to the “CODA Trial – Colitis: Once daily Asacol”.
  • The complainant said the poster led to numerous patients asking for a once-daily prescription of Asacol (mesalazine), creating lengthy discussions with patients who were not eligible for the trial.
  • The complainant believed Asacol was not licensed for once-daily use (SPC stated maintenance therapy: three to six tablets daily in divided doses).
  • The complainant alleged the poster targeted the public (placed in a patient waiting area) and implied better compliance (elephant image; highlighted words), giving “false hope” and causing tension between patients and clinicians.
  • Procter & Gamble (P&G) stated it did not sponsor the trial and had no role in producing or placing the poster; its involvement was limited to an educational grant.
  • The trial sponsor was an NHS trust, which independently produced the poster; wording was reviewed/approved by the Research Ethics Committee (REC). Site recruitment contact details were for a hospital clinical nurse specialist, not P&G.
⚖️

Outcome

  • No breach of the Code was ruled.
  • The Panel decided P&G was not responsible for the poster because it was independently produced and placed by the NHS trust running the study.
  • The Panel noted sympathy with the complainant’s concerns and commented that patient recruitment materials should not inadvertently advertise prescription-only medicines to the public or encourage requests for a specific POM.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training